The Survey About Resting Metabolic Rate and Its Related Factors in Terminal Patients
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Cachectic patients often lose their appetite, lose weight, and are prone to weakness and even death in advanced illness. Nutrition therapy is important and of concern to the investigators in cancer patients. More than 80% of terminal cancer or advanced illness patients get cachexia. Cachexia is a complex, multifactorial syndrome that results from a reduction in food intake, a variety of metabolic abnormalities (including hypermetabolism) or more often a combination of the two. Cachexia will progress with disease progression. Cachexia or weight loss is often the major cause of death or poor quality of life.
The change of resting energy expenditure (REE) is different in various tumor types. Most experts agree that the REE will increase in cancer cachexia syndrome. The more weight loss, the more cachexia will occur.
Overnutrition is not beneficial in terminal patients according to the Chiu and Easson studies. As the investigators know, few studies focus on REE in terminal patients. In this study, samples are from a hospice palliative ward or from hospice home care patients in a medical center in mid-Taiwan. About 100 patients will be recruited. The investigators will analyze the relationship between REE and its related factors. After finishing the study, they will provide more evidence for treating cachexia in terminal patients.
| Condition |
|---|
|
Advanced Cancers |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Cross-Sectional |
| Official Title: | The Survey About Resting Metabolic Rate and Its Related Factors in Terminal Patients |
| Estimated Enrollment: | 100 |
| Study Start Date: | July 2005 |
According to data from the Taiwanese government, cancer mortality has been the leading cause of death in Taiwan since 1982. The trend is increasing day by day. As the people are aging in Taiwan, the incidence of cancer will increase and it will be more important than before.
Cachectic patients often lose their appetite, lose weight, and are prone to weakness and even death in advanced illness. Nutrition therapy is important and of concern to the investigators in cancer patients. More than 80% of terminal cancer or advanced illness patients get cachexia. Cachexia is a complex, multifactorial syndrome that results from a reduction in food intake, a variety of metabolic abnormalities (including hypermetabolism) or more often a combination of the two. Cachexia will progress with disease progression. Cachexia or weight loss is often the major cause of death or poor quality of life.
The change of resting energy expenditure (REE) is different in various tumor types. Most experts agree that the REE will increase in cancer cachexia syndrome. The more weight loss, the more cachexia will occur.
Overnutrition is not beneficial in terminal patients according to the Chiu and Easson studies. As the investigators know, few studies focus on REE in terminal patients. In this study, samples are from a hospice palliative ward or from hospice home care patients in a medical center in mid-Taiwan. About 100 patients will be recruited. The investigators will analyze the relationship between REE and its related factors. After finishing the study, they will provide more evidence for treating cachexia in terminal patients.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
advanced cancer patients
Inclusion Criteria:
- Terminal cancer patients who were admitted to a hospice palliative ward in one medical center located in mid-Taiwan
Exclusion Criteria:
- Patient could not complete the examination of resting metabolic rate using MedGerm
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Wen-Yuan, Lin, China Medical University Hospital |
| ClinicalTrials.gov Identifier: | NCT00208013 History of Changes |
| Other Study ID Numbers: | 94-2314-B-039-025 |
| Study First Received: | September 13, 2005 |
| Last Updated: | November 26, 2010 |
| Health Authority: | Taiwan: Department of Health |
Keywords provided by China Medical University Hospital:
|
resting energy expenditure cachexia advanced cancer advanced cancer patients |
Additional relevant MeSH terms:
|
Neoplasms |
ClinicalTrials.gov processed this record on May 19, 2013